Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03430271 · ClinicalTrials.gov registry record · NA

Enhancing Independence Using Group-based Community Interventions for Healthy AGing in Elders: the ENGAGE Pilot Study

A NA study of Mobility Limitation, sponsored by Tufts University.

Completed
Registry status
NA
Development phase
59
Enrollment target
2
Study locations

NCT03430271 is a NA study of Mobility Limitation that has completed, run by Tufts University. The registered enrollment target is 59 participants, below the 254-participant average among 28 other Mobility Limitation trials with a reported enrollment target (77% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03430271, a NA study of Mobility Limitation, has completed, sponsored by Tufts University.

COMPLETED
Registry status
NA
Development phase
59 participants
Enrollment target
2
Study locations

Study Summary

This study will be conducted to determine the safety and feasibility of translating a physical activity intervention (LIFE Study) into a community setting. Study outcomes include physical performance, safety, and feasibility of conducting the LIFE PA intervention in a community setting.

Conditions Studied

Interventions

  • OTHER Physical Activity Intervention
  • OTHER Healthy Aging Intervention

Study Locations (2)

Massachusetts

  • Jean Mayer Human Nutrition Research Center on Aging at Tufts University - Boston
  • Somerville Council on Aging Holland Street Senior Center - Somerville

Trial Details

FieldValue
Enrollment Target 59 participants
Start Date 2015-05-12
Est. Completion 2016-06-30
Phase NA

Sponsor

Tufts University

163 total trials

What the Registry Record Tells You About NCT03430271

The ClinicalTrials.gov registry entry for NCT03430271 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 59 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 254-participant average among 28 other Mobility Limitation trials with a reported enrollment target (77% lower). The listed sponsor is Tufts University, which has 163 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Mobility Limitation appearing as the primary indexed condition, and to 2 interventions - of which Physical Activity Intervention is the first listed.

NCT03430271 reports 2 study locations spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT03430271 about?

NCT03430271 is a clinical study titled "Enhancing Independence Using Group-based Community Interventions for Healthy AGing in Elders: the ENGAGE Pilot Study". This study will be conducted to determine the safety and feasibility of translating a physical activity intervention (LIFE Study) into a community setting. Study outcomes include physical performance, safety, and feasibility of conducting the LIFE PA intervention in a community setting.

What is the current status of trial NCT03430271?

This trial is currently completed. It is a NA study. The enrollment target is 59 participants. The study started on 2015-05-12. Estimated completion is 2016-06-30.

What conditions does trial NCT03430271 study?

This clinical trial studies the following conditions: Mobility Limitation.

What interventions are being tested in trial NCT03430271?

The interventions under investigation include: Physical Activity Intervention (OTHER), Healthy Aging Intervention (OTHER).

Who is sponsoring clinical trial NCT03430271?

This trial is sponsored by Tufts University, which has 163 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03430271 being conducted?

This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Mobility Limitation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.